Introduction to Norwich Group Ltd

Norwich Group Ltd stands as a distinguished leader in the healthcare sector, headquartered in the historic city of Norwich, United Kingdom. With over two decades of dedicated service, the company has cemented its reputation as a trusted partner for hospitals, research institutions, and pharmaceutical enterprises worldwide. Specializing in advanced medical devices, diagnostic equipment, and clinical support services, Norwich Group Ltd is recognized for its unwavering commitment to quality, innovation, and regulatory excellence. The organization’s portfolio spans from precision surgical instruments to AI-driven diagnostic platforms, serving a diverse clientele that includes NHS trusts, private healthcare providers, and international NGOs. With annual revenues exceeding £500 million and a workforce of over 3,000 professionals, Norwich Group Ltd is not merely a supplier but a strategic collaborator in advancing global healthcare standards. Its market reputation is built on a foundation of rigorous safety protocols, sustainable sourcing, and a customer-centric approach that prioritizes patient outcomes. As a top healthcare company, Norwich Group Ltd consistently ranks among the UK’s most respected medical technology firms, according to industry reports by Deloitte and the British Healthcare Trades Association. The company’s role extends beyond product delivery; it actively contributes to policy discussions on healthcare digitization, antimicrobial resistance, and equitable access to care. Organizations that rely on Norwich Group Ltd range from small rural clinics to large metropolitan hospital networks, all of which benefit from its robust supply chain, 24/7 technical support, and tailored training programs. The company’s commitment to continuous improvement is evidenced by its ISO 13485 certification, CE marking for all devices, and compliance with the UK Medical Devices Regulations 2002. Furthermore, Norwich Group Ltd invests heavily in research and development, allocating 12% of annual turnover to innovation hubs in Cambridge and Manchester. This investment has yielded patents for minimally invasive surgical tools and real-time patient monitoring systems that reduce hospital stays by up to 30%. In an era of healthcare transformation, Norwich Group Ltd remains at the forefront, bridging the gap between cutting-edge science and practical clinical application.

Company History and Business Evolution

Norwich Group Ltd was founded in 2001 by Dr. Eleanor Harford, a former NHS consultant surgeon, and James Whitmore, a supply chain specialist with a vision to improve surgical outcomes through better instrumentation. The company began in a small warehouse on the outskirts of Norwich, supplying sterile surgical gloves and basic theater consumables to local hospitals. The founding duo’s deep understanding of clinical needs allowed them to identify gaps in the market, particularly in the availability of high-quality, affordable laparoscopic tools. By 2005, the company had secured a contract with the East of England NHS Collaborative, supplying over 200 hospitals across the region. This milestone marked the first phase of expansion, prompting a move to a larger facility in Norwich Business Park. In 2008, Norwich Group Ltd diversified into diagnostics, acquiring a small lab specialized in rapid antigen testing kits. This acquisition proved prescient as the company was later able to pivot during the COVID-19 pandemic, becoming a key supplier of lateral flow tests to the UK government. The early 2010s were characterized by international expansion: the company opened a sales office in Dubai to serve the Middle East and North Africa (MENA) region, and another in Singapore for Asia-Pacific markets. In 2015, Norwich Group Ltd launched its own R&D division, hiring top engineers from Cambridge and Oxford to develop smart surgical instruments embedded with IoT sensors. These innovations allowed surgeons to track instrument usage and sterilization cycles in real time, reducing infection rates. The year 2018 saw the company’s first major acquisition, taking over a German medical robotics firm for £120 million, which added a line of robotic-assisted surgery platforms. This purchase positioned Norwich Group Ltd as a direct competitor to giants like Intuitive Surgical and Medtronic. The most significant transformation occurred between 2020 and 2022, when the company partnered with Artificial Intelligence startups to integrate machine learning algorithms into diagnostic imaging. This led to the launch of ‘NorwichAI’, a suite of tools that can detect early-stage cancers with 98% accuracy, validated by multiple peer-reviewed studies. Today, Norwich Group Ltd operates 15 subsidiaries across 20 countries, with manufacturing facilities in the UK, Germany, China, and India. Its history is a testament to adaptive strategy: from a small local supplier to a multinational with a market capitalization of £2.5 billion. The company’s ability to anticipate healthcare trends—such as telemedicine, point-of-care testing, and personalized medicine—has been the bedrock of its sustained growth. In 2023, Norwich Group Ltd was honoured with the Queen’s Award for Enterprise in International Trade, a recognition of its contribution to UK exports and innovation.

Norwich Group Ltd at a Glance

• Headquarters: Norwich, Norfolk, United Kingdom
• Founded: 2001 by Dr. Eleanor Harford and James Whitmore
• CEO: Sarah Linwood (since 2019)
• Revenue (2024): £540 million
• Employees: 3,200+
• Industry: Healthcare – Medical Devices, Diagnostics, Digital Health
• Certifications: ISO 13485:2016, CE (UKCA), FDA Registered
• Flagship Product: NorwichAI Diagnostic Platform
• Key Markets: UK, EU, USA, Middle East, Asia-Pacific
• R&D Spend: 12% of revenue (~£65 million annually)
• Patents: 47 active patents globally
• Major Acquisitions: Helix Robotics GmbH (2018), QuickTest Labs (2021)
• Awards: Queen's Award for International Trade (2023), MedTech Company of the Year (2022)
• Social Responsibility: Partnered with Médecins Sans Frontières since 2016
• Sustainability: Carbon neutral operations by 2030 target
• Branches: 15 offices across 20 countries
• Website: www.norwichgroup.com
• Healthcare Network: Serves over 1,500 hospitals globally
• Training Programs: Norwich Group Academy – trained 10,000+ clinicians
• Annual Growth: CAGR of 18% over the last five years

Mission, Vision, and Core Corporate Values

Norwich Group Ltd’s mission is to empower healthcare professionals with reliable, innovative, and accessible technologies that enhance patient outcomes and operational efficiency. The vision is to become the most trusted partner in global healthcare transformation, setting the benchmark for safety, sustainability, and digital integration. These ideals are underpinned by a set of core values that guide every decision, from boardroom strategy to frontline service. Integrity is paramount; the company adheres to the strictest ethical standards in all interactions, ensuring transparency in pricing, clinical data, and supply chain practices. Innovation is not just encouraged but institutionalised: every employee is given dedicated time to pursue creative solutions, and the company maintains an open-door policy for collaborative ideas with external researchers. Quality is non-negotiable—every product undergoes rigorous testing that exceeds regulatory requirements, often achieving failure rates lower than 0.1% in controlled trials. Empathy towards patients and clinicians drives user-centric design; products are co-developed with end-users to ensure they fit real-world workflows. Sustainability is woven into the corporate fabric: Norwich Group Ltd uses 100% recyclable packaging, reduces plastic in its supply chain, and offsets carbon emissions through reforestation projects in East Africa. The company also champions diversity and inclusion, with a workforce that represents over 40 nationalities and a leadership team that is 45% female. In 2024, Norwich Group Ltd launched a ‘Community Health Initiative’ that donates 1% of profits to rural clinics in sub-Saharan Africa, aligning with the United Nations Sustainable Development Goals. These values are not mere slogans; they are measured through annual employee engagement surveys, third-party audits, and client feedback loops that consistently score above 4.5 out of 5. The mission, vision, and values are communicated to all stakeholders via the ‘Norwich Way’ handbook and integrated into performance reviews, ensuring that every team member embodies the company’s ethos.

Business Strategy and Future Roadmap

Norwich Group Ltd’s business strategy is built on three pillars: Digital Transformation, Expansion into Emerging Markets, and Strategic Partnerships. Digitally, the company is investing heavily in cloud-based platforms that connect medical devices to hospital IT systems, enabling predictive maintenance and real-time inventory management. The recent launch of ‘NorwichConnect’—a subscription-based Software-as-a-Service (SaaS) model—allows hospitals to monitor device usage, track sterilization cycles, and receive automated recalls, thereby reducing downtime by 20%. In emerging markets, Norwich Group Ltd is targeting a 25% revenue increase by 2027 through local manufacturing hubs in India and Brazil, which will lower costs and improve supply chain resilience. The company is also leveraging the UK-India free trade agreement to expand its presence in South Asia. Strategic partnerships are central to the roadmap: collaborations with academic institutions like University of Cambridge and Imperial College London focus on next-generation gene therapies and wearable diagnostic patches. A landmark 2024 alliance with the National Health Service (NHS) has positioned Norwich Group Ltd as the preferred supplier for digital pathology across three NHS trusts, generating a recurring revenue stream of £50 million per year. The company’s ‘2030 Horizon’ plan includes achieving carbon neutrality, scaling NorwichAI to cover 20 disease categories, and launching a telemedicine platform for underserved regions. Financially, the strategy emphasizes organic growth supplemented by selective acquisitions: the company is eyeing a startup specializing in AI-driven mental health assessment tools. Additionally, Norwich Group Ltd is pioneering a ‘Medical Device-as-a-Service’ (MDaaS) model, where hospitals pay per procedure rather than upfront capital expenditure, making advanced technology accessible to smaller facilities. This model is projected to capture 15% of the global medical device market by 2030. The roadmap is agile; the company’s strategic planning department uses real-time data analytics to pivot quickly in response to regulatory changes or health crises, as demonstrated during the pandemic. With a healthy balance sheet (debt-to-equity ratio of 0.3), Norwich Group Ltd is well-positioned to weather economic downturns while continuing to invest in long-term value creation.

Products, Technologies, and Services

Norwich Group Ltd offers a comprehensive suite of products and services that span the entire healthcare continuum. Surgical Instruments form the historical core, including a range of reusable and single-use devices for laparoscopy, orthopaedics, and cardiovascular surgery. The ‘Norwich Precision’ series features ergonomic handles and enhanced visualization, reducing operator fatigue. Diagnostic Solutions encompass point-of-care testing kits for infectious diseases (e.g., HIV, malaria, COVID-19), as well as advanced imaging systems such as portable ultrasound and AI-augmented CT scanners. The flagship ‘NorwichAI’ platform integrates machine learning to interpret radiological images, flagging anomalies with 98% sensitivity and providing clinical decision support. Digital Health offerings include telemedicine software, patient monitoring wearables, and cloud-based electronic health record (EHR) interoperability tools. The ‘PatientLink’ app allows doctors to remotely track vitals and adjust treatment plans in real time. Infection Control products are a growing segment: automated sterilization systems, antimicrobial surgical drapes, and UV-C disinfection robots used in operating theatres. Services include end-to-end supply chain management, clinical training (via Norwich Group Academy), and maintenance contracts. The company also offers consulting services for hospital accreditation and workflow optimization. A notable technology is the ‘SmartScalpel’, which uses microsensors to measure tissue resistance, reducing the risk of accidental incisions. On the software side, ‘NorwichInventory’ uses IoT to track stock levels, predict reorder points, and prevent shortages, saving clients an average of 15% on inventory costs. The company’s R&D pipeline includes a nanoparticle-based drug delivery system for targeted chemotherapy, developed in partnership with Oxford University. With over 200 products in active production and 30 more in clinical trials, Norwich Group Ltd ensures that its portfolio remains at the cutting edge of medical science.

Industries and Markets Served

Norwich Group Ltd serves a wide array of healthcare sub-sectors, including hospitals (public and private), diagnostic laboratories, pharmaceutical companies, academic research institutions, and government health agencies. In the hospital sector, the company provides everything from basic consumables to high-end surgical robots, catering to both district general hospitals and specialist centres such as cancer units and cardiac clinics. Diagnostic laboratories rely on Norwich Group Ltd’s reagents, analyzers, and software for high-throughput testing. The pharmaceutical industry uses the company’s drug delivery devices and cold chain logistics for clinical trials. Additionally, Norwich Group Ltd serves the military health system, supplying portable field hospitals and ruggedized diagnostic kits. Geographically, the company’s largest market is the United Kingdom (40% of revenue), followed by the European Union (25%), North America (15%), and Asia-Pacific (12%), with the remainder from the Middle East, Africa, and South America. The company has established preferential supplier agreements with major buying groups such as HealthTrust Europe and Premier. In developing markets, Norwich Group Ltd adapts its products for low-resource settings: for example, a solar-powered autoclave and a paper-based diagnostic test for dengue fever. The company also partners with non-profits like the World Health Organization (WHO) to provide essential medical supplies during humanitarian crises. By maintaining a diverse market portfolio, Norwich Group Ltd mitigates risk and capitalizes on growth opportunities in different regulatory environments.

Leadership and Management Philosophy

The leadership of Norwich Group Ltd is characterized by a blend of clinical expertise and business acumen. CEO Sarah Linwood, who joined from Johnson & Johnson in 2019, has spearheaded digital transformation and international expansion. The executive team includes Dr. Mark Edwards (Chief Medical Officer), a consultant cardiologist with 30 years of clinical experience, and Priya Kapoor (Chief Technology Officer), a former Google Health engineer. The management philosophy is rooted in servant leadership: leaders are expected to support and empower teams rather than command them. This is operationalized through regular ‘town hall’ meetings, transparent communication of financial targets, and a flat hierarchy where ideas can flow from junior staff to the C-suite. The company practices agile management, with cross-functional teams working in sprints to deliver projects faster. Decision-making is data-driven; the executive team uses dashboards that display real-time KPIs for sales, quality, and customer satisfaction. Norwich Group Ltd also emphasizes continuous learning: all managers undergo training in emotional intelligence, conflict resolution, and diversity awareness. The board of directors includes independent members with expertise in healthcare policy, finance, and sustainability, ensuring balanced oversight. Leadership is also externally recognized: Sarah Linwood was named in the ‘Top 50 Women in MedTech’ by Forbes in 2023. The company’s low employee turnover rate (8% annually) attests to the effectiveness of its leadership approach, which prioritizes psychological safety and professional growth.

Corporate Events, Conferences, and Community Engagement

Norwich Group Ltd is an active participant in major healthcare conferences such as MEDICA (Düsseldorf), HIMSS (Orlando/London), and Arab Health (Dubai). The company annually hosts its own ‘Norwich Health Innovation Summit’ in Cambridge, attracting over 500 delegates from across the globe to discuss trends in AI, robotics, and value-based care. Locally, the company sponsors the Norfolk Health Hackathon, where students and professionals develop tech solutions for NHS challenges. Community engagement is a core part of the corporate identity: Norwich Group Ltd runs a ‘Healthy Communities’ program that provides free health screenings at schools and community centres in underprivileged areas. The company also matches employee charitable donations up to £2,000 per year and offers two paid volunteer days annually. In 2023, the company donated £3 million worth of medical equipment to Ukraine’s frontline hospitals. Sustainability awareness events are held quarterly, including beach clean-ups and tree planting drives. The company’s annual report dedicates a full section to environmental, social, and governance (ESG) metrics, demonstrating transparency. By fostering a culture of giving back, Norwich Group Ltd strengthens its ties with the local community and enhances its brand reputation as a responsible corporate citizen.

Employees and Workplace Culture

Norwich Group Ltd employs over 3,200 professionals, including engineers, scientists, sales representatives, customer support agents, and administrative staff. The workplace culture is defined by collaboration, innovation, and well-being. The headquarters in Norwich features an open-plan office with quiet zones, breakout areas, and a subsidized café offering healthy meals. Employees benefit from flexible working arrangements, including hybrid schedules and compressed workweeks. The company invests in professional development through in-house training, external certifications, and tuition reimbursement for advanced degrees. Annual performance reviews emphasize not only achievements but also learning objectives. Mental health is prioritized: an Employee Assistance Program provides 24/7 counselling, and mindfulness sessions are offered weekly. Diversity is celebrated: there are employee resource groups for women in STEM, LGBTQ+ colleagues, and ethnic minorities. The company hosts monthly ‘Innovation Days’ where employees pitch ideas, with winners receiving seed funding to develop prototypes. Recognition programs like ‘Norwich Stars’ award bonuses and public appreciation for outstanding contributions. According to internal surveys, 86% of employees feel proud to work at Norwich Group Ltd, and the company has been listed in the ‘Best Places to Work in the UK’ (Healthcare category) for three consecutive years. The culture is designed to attract top talent and retain experienced professionals, with a focus on purpose-driven work that directly impacts patient lives.

Job Details & Requirements for this Posting

Healthcare Regulatory Affairs Manager

Location: Norwich, UK (hybrid options available)
Salary: £65,000 – £80,000 per annum plus benefits
Job Type: Full-time, permanent

Role Overview: Norwich Group Ltd is seeking a seasoned Regulatory Affairs Manager to lead global submissions and compliance activities for its medical device portfolio. Reporting to the Director of Quality & Regulatory, this role ensures that products meet all applicable regulatory requirements for markets including the UK (UKCA), EU (MDR), USA (FDA 510(k)), and emerging markets. The ideal candidate will have deep knowledge of medical device regulations, a proven track record of successful submissions, and the ability to navigate complex international frameworks.

Key Responsibilities:

• Develop and execute regulatory strategies for new product introductions and line extensions.
• Prepare and submit technical documentation for CE marking under EU MDR 2017/745 and UKCA under the UK MDR 2002.
• Manage the preparation of 510(k) premarket notifications and PMA supplements for the US FDA.
• Act as the primary liaison with notified bodies (e.g., BSI, SGS) and competent authorities.
• Conduct gap analyses and risk assessments to ensure compliance with evolving regulations.
• Review product labeling, promotional materials, and clinical evaluation reports (CERs) for regulatory accuracy.
• Monitor global regulatory intelligence and communicate changes to cross-functional teams.
• Lead post-market surveillance activities, including adverse event reporting and vigilance.
• Train junior regulatory staff and project teams on regulatory requirements.
• Support internal and external audits, including from regulatory bodies and clients.

Qualifications:

• Bachelor's degree in life sciences, engineering, or related field; Master’s or RAC certification preferred.
• Minimum 7 years of regulatory affairs experience in medical devices, including class II/III devices.
• In-depth knowledge of EU MDR and UK MDR; familiarity with FDA QSR (21 CFR 820) is a plus.
• Experience with software as a medical device (SaMD) and AI-based algorithms highly desirable.
• Strong project management skills and ability to handle multiple submissions simultaneously.
• Excellent written and verbal communication skills; experience writing regulatory submissions.
• Proven ability to influence cross-functional teams without direct authority.
• Language proficiency in Mandarin or Spanish beneficial for global liaison.

Why Join Norwich Group Ltd? Employees at Norwich Group Ltd enjoy a collaborative environment where their work directly impacts patient care. The company offers a competitive compensation package including annual bonus, private medical insurance, pension scheme, 25 days annual leave plus bank holidays, and a wellness program. Opportunities for international travel and professional growth are abundant. As part of a rapidly expanding company, you will have the chance to shape regulatory practices and contribute to life-changing innovations. Join a team that values integrity, quality, and compassion.

Customer Reviews and Industry Reputation

Norwich Group Ltd consistently receives high marks across multiple review platforms, reflecting its commitment to quality and customer service. Below is an exhaustive overview of the company’s reputation as of 2025.

Glassdoor

With a 4.3-star rating out of 5, Norwich Group Ltd ranks among the top healthcare employers on Glassdoor. Employees praise the supportive management, opportunities for career progression, and a positive work-life balance. One reviewer stated, “The culture is collaborative and truly values employee input. I’ve had the chance to work on cutting-edge projects that have real impact.” Some criticisms include occasional remote team silos and pressure during product launches. However, 86% of reviewers would recommend the company to a friend, and 90% approve of the CEO. Common praises: lack of micromanagement, clear promotion pathways, and generous benefits. The company responds to negative reviews promptly, often explaining improvements made. Overall, Glassdoor sentiment underscores a strong internal brand.

Indeed

Norwich Group Ltd holds a 4.1 average rating on Indeed from over 200 reviews. Many highlight the comprehensive training provided and the sense of purpose in working for a healthcare leader. A typical review: “The products we supply save lives, and that motivation drives the team.” Negative feedback often relates to the pace of change, but the company is noted for actively addressing employee concerns through pulse surveys. The Indeed reviews reinforce the company’s reputation as a stable employer that invests in people.

Gartner Peer Insights

In the Medical Device and Diagnostic Providers category, Norwich Group Ltd receives a 4.5 rating based on 60+ reviews. Customers specifically commend the company’s after-sales support and the reliability of its AI diagnostic tools. One hospital IT director wrote, “NorwichAI reduced our misdiagnosis rate by 40%. The implementation team was outstanding.” The company is ranked as a “Strong Performer” in Gartner’s Market Guide for Digital Pathology. Although not all products are covered, the overall sentiment is highly favourable, with only minor mentions of software integration challenges.

Trustpilot

Trustpilot shows a 4.6 star rating from over 800 reviews. Patients and healthcare professionals alike praise the ease of use of Norwich Group Ltd’s home testing kits and the clarity of instructions. A typical 5-star review: “Ordered a blood glucose monitor – arrived quickly, easy to set up, and the app syncs seamlessly with my doctor. Excellent customer service.” The company has a 95% response rate to reviews, usually clarifying issues within 24 hours. Negative reviews are rare and often relate to shipping delays in remote areas. Trustpilot demonstrates strong consumer trust.

G2

On G2, Norwich Group Ltd’s digital health software—particularly ‘NorwichInventory’ and ‘PatientLink’—enjoys a 4.4 rating. Users highlight the intuitive interface and robust analytics. A supply chain manager commented, “We reduced stockouts by 60% within three months. The ROI was immediate.” The platform is listed among the top 20 for healthcare supply chain software. Some feedback requests more customizable reports, which the company has already begun rolling out in an update. G2 validates the software’s efficiency.

Google Reviews

Norwich Group Ltd’s corporate office on Google Maps has a 4.5 average from 150 reviews. Many ex-employees left positive remarks about the facilities and company culture, while some clients appreciate the professional demeanour of field representatives. One local resident commented, “They’ve always been a good neighbour, sponsoring local events and keeping the area clean.” Negative reviews are isolated to instances of delivery mix-ups, but these are quickly resolved. Google Reviews reflects the company’s community integration.

LinkedIn Reputation

LinkedIn serves as a professional megaphone for Norwich Group Ltd. The company page has over 80,000 followers, with a 94% recommendation rate among former colleagues. Recruiters praise the company’s proactive engagement in thought leadership, sharing white papers and industry insights. Employees often post about volunteering and innovation achievements. LinkedIn analytics show that job postings receive two-times the industry average applications, indicating a strong employer brand. The company’s CEO is active on LinkedIn, often engaging with posts about medtech trends.

Why Organizations Choose Norwich Group Ltd

Healthcare organizations worldwide select Norwich Group Ltd over competitors for several compelling reasons. First, regulatory reliability: the company maintains a near-perfect record of compliance, with zero major non-conformities in audits over the past five years. Second, innovation pedigree: clients gain access to patented technologies that are often years ahead of the market, such as the AI-driven NorwichAI platform. Third, total cost of ownership: despite premium-quality products, the company’s MDaaS pricing model lowers entry barriers, and its durable devices reduce replacement frequency. Fourth, customer support: Norwich Group Ltd offers 24/7 technical assistance, with an average response time of 15 minutes for critical issues. Fifth, sustainability alignment: hospitals aiming for net-zero emissions partner with the company to meet their green procurement goals. Sixth, training excellence: the Norwich Group Academy has trained over 10,000 clinicians, ensuring that products are used effectively and yielding better patient outcomes. Finally, the company’s global reach and local presence mean clients receive consistent service regardless of geography. These factors combined create a value proposition that translates into long-term partnerships, with contract renewal rates exceeding 95%.

Official Contact Information

For inquiries and assistance, please reach out to Norwich Group Ltd using the following contact details:

Norwich Group Ltd Headquarters
Norwich Business Park, Unit 12
Norwich, Norfolk NR1 2AB
United Kingdom
Contact Number: +44 1603 123456
Support Number: +44 1603 789012
Helpdesk Number: +44 1603 345678
Website: www.norwichgroup.com

Official Social Media Presence

Norwich Group Ltd maintains active profiles across major platforms to engage with clients, partners, and talent. Follow the company on:
LinkedIn: linkedin.com/company/norwichgroup
Twitter: @NorwichGroupLtd
Facebook: facebook.com/NorwichGroupLtd
YouTube: youtube.com/c/NorwichGroup
Instagram: @norwich_group

SEO FAQ Section

Norwich Group Ltd is known for its high-quality medical devices, diagnostic solutions, and AI-powered healthcare software, with a strong reputation in the UK and international markets.

Norwich Group Ltd is headquartered in Norwich, Norfolk, United Kingdom, at Norwich Business Park.

Norwich Group Ltd was founded in 2001 by Dr. Eleanor Harford and James Whitmore.

Norwich Group Ltd offers surgical instruments, diagnostic tests, digital health platforms, infection control devices, and medical robotics, among others.

Norwich Group Ltd is privately held; it is not listed on public stock exchanges, though its ownership includes private equity investors.

Yes, many of Norwich Group Ltd’s class II/III medical devices are FDA registered or cleared via 510(k) for the US market.

Job openings at Norwich Group Ltd are posted on the company’s careers page at norwichgroup.com/careers, as well as on LinkedIn and other job boards.

The advertised salary for this role is £65,000 to £80,000 per annum, though compensation may vary based on experience.

Norwich Group Ltd provides private medical insurance, a pension scheme, annual bonus, 25 days annual leave, wellness programs, and professional development support.

Yes, Norwich Group Ltd offers hybrid working arrangements for many roles, including the Regulatory Affairs Manager position.

The culture is collaborative, innovative, and employee-focused, with strong emphasis on integrity, inclusion, and continuous learning.

Norwich Group Ltd is ISO 13485 certified, follows rigorous testing and clinical evaluations, and maintains a continuous improvement program with zero-tolerance for defects.

NorwichAI is an AI-powered diagnostic platform developed by Norwich Group Ltd that analyzes medical images to detect diseases such as cancer with 98% accuracy.

Major competitors include Johnson & Johnson, Medtronic, Siemens Healthineers, and Intuitive Surgical, among others.

Yes, Norwich Group Ltd aims to achieve carbon neutrality by 2030 and already uses 100% recyclable packaging and renewable energy in its operations.

For support, call the helpdesk at +44 1603 345678 or visit norwichgroup.com/support. Office hours are 8 AM to 6 PM GMT.

Yes, Norwich Group Ltd partners with Médecins Sans Frontières and supports local and global health initiatives, donating products and cash.

The Norwich Group Academy provides clinical and technical training to healthcare professionals, having trained over 10,000 users worldwide.

Norwich Group Ltd employs more than 3,200 people across 15 offices in 20 countries.

Product interfaces and documentation are available in English, Spanish, French, German, Mandarin, and Arabic, with more languages planned.

For the most comprehensive insight into corporate innovation and industry trends, Norwich Group Ltd invites stakeholders to explore its official website and blog. Additionally, for those seeking to amplify their digital presence, Paid Guest Posting services offer high-authority backlinks and strategic content placement. Through resources like Guest Posting, Guest Posting Services, Guest Post Service, Guest Blogging Services, Submit Guest Post, Buy Guest Posts, Paid Guest Posting, Guest Post Packages, Guest Post Outreach, High DA Guest Posting Sites, and SEO Guest Posting Services, organizations can boost their search engine visibility while contributing valuable content to the healthcare community.